Cite
Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
MLA
Chavoustie, Steven E., et al. “Two Phase 3, Double-Blind, Placebo-Controlled Studies of the Efficacy and Safety of Astodrimer 1% Gel for the Treatment of Bacterial Vaginosis.” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 245, Feb. 2020, pp. 13–18. EBSCOhost, https://doi.org/10.1016/j.ejogrb.2019.11.032.
APA
Chavoustie, S. E., Carter, B. A., Waldbaum, A. S., Donders, G. G. G., Peters, K. H., Schwebke, J. R., Paull, J. R. A., Price, C. F., Castellarnau, A., McCloud, P., & Kinghorn, G. R. (2020). Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 245, 13–18. https://doi.org/10.1016/j.ejogrb.2019.11.032
Chicago
Chavoustie, Steven E, Belvia A Carter, Arthur S Waldbaum, Gilbert G G Donders, Klaus H Peters, Jane R Schwebke, Jeremy R A Paull, et al. 2020. “Two Phase 3, Double-Blind, Placebo-Controlled Studies of the Efficacy and Safety of Astodrimer 1% Gel for the Treatment of Bacterial Vaginosis.” European Journal of Obstetrics, Gynecology, and Reproductive Biology 245 (February): 13–18. doi:10.1016/j.ejogrb.2019.11.032.